On September 25, 2019 Viking Therapeutics, Inc. ("Viking") (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, reported that the company will deliver a corporate presentation at the 2019 Cantor Global Healthcare Conference, being held October 2-4, 2019 in New York, NY (Press release, Viking Global Investors, SEP 25, 2019, View Source [SID1234539790]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Details for this presentation are as follows:

2019 Cantor Global Healthcare Conference – webcast available
Time/Date: 4:45 p.m. Eastern on Wednesday, October 2, 2019
Location: InterContinental New York Barclay Hotel
Room: Grand Ballroom 2
To access the live webcast of Viking’s presentation, please visit "Webcasts & Presentations" within the News & Events section of Viking’s Investors page at www.vikingtherapeutics.com. Additionally, a replay of the webcast will be available on the Viking website following the conference.